• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Weekly dynamics, subtype replacement and regional heterogeneity of influenza activity in China, 2024-2026: A national sentinel surveillance

tetano

Editor, Senior Moderator
PLoS One

. 2026 Nov 4;21(11):e0361588.
doi: 10.1371/journal.pone.0361588. eCollection 2026.

Weekly dynamics, subtype replacement and regional heterogeneity of influenza activity in China, 2024-2026: A national sentinel surveillance analysis​


Simin Wang 1 2 , Zhi Xia 1 2 , Buyun Shi 1 2 3 , Ming Chen 4 , Xiaolan Shu 2 , Pan Peng 2

Affiliations Expand


Abstract​


Objective: National influenza surveillance in China is reported weekly, but recent post-pandemic patterns integrating regional timing, subtype/lineage replacement and outbreak activity have not been quantitatively characterized in a continuous national series. We aimed to reconstruct and quantify weekly influenza dynamics in China from 2024/W01 to 2026/W21.


Methods: We performed a retrospective secondary time-series analysis of 125 publicly available, aggregate weekly reports from the Chinese Center for Disease Control and Prevention and Chinese National Influenza Center. Values were reconciled against official reports when working datasets differed or quality-control checks identified inconsistencies. Positivity was recalculated from positive and tested specimens. Regional differences were evaluated across paired weeks using heteroskedasticity- and autocorrelation-consistent Newey-West standard errors and exploratory lead-lag relationships were assessed using cross-correlation of first-differenced weekly series.


Results: Nationally, 1,796,636 influenza-like illness specimens were tested and 253,219 were influenza-positive (weighted positivity, 14.1%); national positivity peaked in 2025/W49 at 49.8%. Overall weighted positivity was 14.6% in Southern China and 13.3% in Northern China. Across 125 paired weeks, Southern China had a mean positivity 4.41 percentage points higher than Northern China (95% CI, 2.23-6.59; P < 0.001) and a mean ILI percentage 0.77 points higher (95% CI, 0.48-1.05; P < 0.001). First-difference positivity changes were most strongly correlated when Northern China led Southern China by one week (r = 0.781). Among 253,104 explicitly reported subtype/lineage detections, A(H3N2) was largest (45.6%), followed by A(H1N1)pdm09 (33.8%) and B(Victoria) (20.6%). Predominance followed A(H3N2) in 2024/W01, B(Victoria), A(H1N1)pdm09, A(H3N2) and B(Victoria) again in early 2026. Reported outbreaks peaked in 2025/W48 at 1,541, during A(H3N2) predominance.


Conclusions: Recent influenza activity in China was multi-wave and regionally heterogeneous, with measurable north-south temporal differences, sequential subtype replacement and a large A(H3N2)-associated outbreak surge. The analysis also demonstrates the importance of explicit source-level quality control when reusing aggregated public surveillance reports.
 
Back
Top Bottom